These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6131948)

  • 21. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y; Fage D; Zivkovic B; Scatton B
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P; Lesourd M; Comoy E
    Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible anomalous behaviour of apomorphine in relation to other dopamine receptor agonists.
    Feenstra MG; Goedemoed JH; Rollema H; Horn AS
    J Pharm Pharmacol; 1983 Jul; 35(7):471-3. PubMed ID: 6136595
    [No Abstract]   [Full Text] [Related]  

  • 24. Differential effects of the enantiomers of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP) at dopamine receptor sites.
    Koch SW; Koe BK; Bacopoulos NG
    Eur J Pharmacol; 1983 Sep; 92(3-4):279-83. PubMed ID: 6138267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of 5-hydroxytryptophan and 5-hydroxytryptamine on dopamine synthesis and release in rat brain striatal synaptosomes.
    Andrews DW; Patrick RL; Barchas JD
    J Neurochem; 1978 Feb; 30(2):465-70. PubMed ID: 24089
    [No Abstract]   [Full Text] [Related]  

  • 26. Chronic cocaine treatment impairs the regulation of synaptosomal 3H-DA release by D2 autoreceptors.
    Yi SJ; Johnson KM
    Pharmacol Biochem Behav; 1990 Jul; 36(3):457-61. PubMed ID: 1974064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Buspirone analogues. 1. Structure-activity relationships in a series of N-aryl- and heteroarylpiperazine derivatives.
    Yevich JP; Temple DL; New JS; Taylor DP; Riblet LA
    J Med Chem; 1983 Feb; 26(2):194-203. PubMed ID: 6131130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine-synthesis and tyrosine-hydroxylase are regulated by independent DA-receptor mediated mechanisms.
    Tissari HA; Porceddu ML; Argiolas A; Di Chiara G; Gessa GL
    Life Sci; 1978 Aug; 23(6):653-8. PubMed ID: 29202
    [No Abstract]   [Full Text] [Related]  

  • 29. Disinhibitory effects of buspirone and low doses of sulpiride and haloperidol in two experimental anxiety models in rats: possible role of dopamine.
    Pich EM; Samanin R
    Psychopharmacology (Berl); 1986; 89(1):125-30. PubMed ID: 2874581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of apomorphine in vitro on the uptake and release of catecholamines in crude synaptosomal preparations of rat striatum and hypothalamus.
    Ferris RM; Tang FL; Russell AV
    Biochem Pharmacol; 1975 Aug; 24(16):1523-7. PubMed ID: 1191310
    [No Abstract]   [Full Text] [Related]  

  • 31. The anxiolytic serotonin 5-HT1A receptor agonists buspirone, ipsapirone and gepirone are inhibitors of tyrosine hydroxylation in rat striatum.
    Johnson EA; Fox JL; Azzaro AJ
    Behav Brain Res; 1996; 73(1-2):331-5. PubMed ID: 8788529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3-Methoxytyramine accumulation: effects of typical neuroleptics and various atypical compounds.
    Saller CF; Salama AI
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):125-32. PubMed ID: 2878374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presynaptic dopamine receptors in striatal nerve endings: absence of haloperidol-induced supersensitivity.
    Raiteri M; Cerrito F; Casazza G; Levi G
    Adv Biochem Psychopharmacol; 1980; 24():37-43. PubMed ID: 7405669
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of apomorphine-induced conditioned place preference in rats co-injected with buspirone: relationship with serotonin and dopamine in the striatum.
    Haleem DJ; Ikram H; Haleem MA
    Brain Res; 2014 Oct; 1586():73-82. PubMed ID: 25160128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apomorphine enantiomers' effects on dopamine metabolism: receptor and non-receptor related actions.
    Saller CF; Salama AI
    Eur J Pharmacol; 1986 Feb; 121(2):181-8. PubMed ID: 3699091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity.
    Creese I; Burt DR; Snyder SH
    Science; 1977 Aug; 197(4303):596-8. PubMed ID: 877576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Buspirone analogues. 2. Structure-activity relationships of aromatic imide derivatives.
    New JS; Yevich JP; Eison MS; Taylor DP; Eison AS; Riblet LA; VanderMaelen CP; Temple DL
    J Med Chem; 1986 Aug; 29(8):1476-82. PubMed ID: 2874226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cocaine administration: D1 dopamine receptor function and dopamine clearance/diffusion in rat striatum and nucleus accumbens.
    Zahniser NR; Mayfield RD; Cass WA; Gerhardt GA
    Ann N Y Acad Sci; 1992 Jun; 654():537-9. PubMed ID: 1385936
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential regulation of dopamine metabolism in solid fetal substantia nigra transplants and their terminals in the host striatum.
    Meloni R; Gale K
    Prog Brain Res; 1990; 82():467-71. PubMed ID: 2127112
    [No Abstract]   [Full Text] [Related]  

  • 40. In vivo and in vitro evidence of dopaminergic system down regulation induced by chronic L-DOPA.
    Ponzio F; Cimino M; Achilli G; Lipartiti M; Perego C; Vantini G; Algeri S
    Life Sci; 1984 May; 34(22):2107-16. PubMed ID: 6145075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.